advanced search
Christoph Egloff
Chief Technology Officer

Is this your profile?

About

Christoph Egloff is the Chief Technology Officer at Weibel CDS. His role covers innovation, technical design, management of the engineering department and project management. Mr Egloff worked on the manufacturing, installation and qualification of SuperCapSyringe®, and development, testing and production for the LyCaJect project.

Contributions

WEARABLES
LARGE-VOLUME WEARABLE DRUG DELIVERY: A VISION BECOMES REALITY
Hans Peter Manser, Christoph Egloff and Martin C King introduce LV DDS , a flexible-form, low-profile wearable injector platform, for large-volume drug delivery.

More contributions

PREFILLED SYRINGES
LYCAJECT: AUTOMATIC RECONSTITUTION PATCH INJECTOR
Hans Peter Manser, Christoph Egloff and Martin C King introduce the LyCaJect Patch Injector, Weibel CDS’ offering in the field of wearable injectors, with automatic reconstitution as a headline feature.
Top